2018
DOI: 10.5935/0946-5448.20180027
|View full text |Cite
|
Sign up to set email alerts
|

Otolaryngologic Symptoms in Multiple Sclerosis: A Review

Abstract: Many symptoms of multiple sclerosis may affect the ear, nose and throat. The most common otolaryngologic symptoms of multiple sclerosis are speech disorders, followed by sleep disorders, vertigo and disequilibrium, dysphagia, smell alterations, and hearing loss. Less common symptoms include sialorrhea, facial palsy, taste alterations, trigeminal neuralgia and tinnitus. The origin of otolaryngologic symptoms in multiple sclerosis is mainly central, although increasing evidence also suggests a peripheral involve… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

1
0
0

Year Published

2019
2019
2023
2023

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 5 publications
(1 citation statement)
references
References 120 publications
(142 reference statements)
1
0
0
Order By: Relevance
“…Various otorhinolaryngological symptoms are also described in MS, including speech disorders, sleep disorders, vertigo, imbalance, dysphagia, changes in smell, and hearing loss. 40 These data, along with the present study's findings, make clear the importance of otorhinolaryngological and speech-language-hearing follow-ups on children and adolescents with MS. This study had a larger sample than the previous one that assessed auditory evoked potentials in same-age MS patients.…”
Section: Discussionsupporting
confidence: 78%
“…Various otorhinolaryngological symptoms are also described in MS, including speech disorders, sleep disorders, vertigo, imbalance, dysphagia, changes in smell, and hearing loss. 40 These data, along with the present study's findings, make clear the importance of otorhinolaryngological and speech-language-hearing follow-ups on children and adolescents with MS. This study had a larger sample than the previous one that assessed auditory evoked potentials in same-age MS patients.…”
Section: Discussionsupporting
confidence: 78%